Home > NRC Library > ADAMS Public Documents

631905 Amendment No. 5 for POINT Biopharma USA Inc. to License No. 13-35593-01

Accession Number: ML22252A012

Date Released: Thursday, September 15, 2022

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML22252A008 - 631905 Cover Letter for POINT Biopharma USA Inc. to License No. 13-35593-01 (2 page(s), 9/8/2022)
• ML22243A012 - 631905 Additional Information Request for POINT Biopharma USA Inc. to License No. 13-35593-01 (1 page(s), 8/30/2022)